Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 16 | Rothblatt Martine ADirector, Chairperson & CEO |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $407K 720 sh |
| Nov 6, 2026 traded Nov 5, 2026 |
| 15 | Tan FionaChief Technology Officer |  WWayfair Inc.Open-market sale · 10b5-1 plan | SELL | $1.00M 8,000 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 15 | Corbin Charles R. Jr.See Remarks |  HGVHilton Grand Vacations Inc.Open-market sale · 10b5-1 plan | SELL | $838K 19.6K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 15 | Peters William JDirector, CFO, EVP & TREASURER |  AMPHAmphastar Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $448K 16.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 15 | Kelley Shannon TGeneral Counsel |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $431K 1,077 sh | Nov 6, 2026 traded Nov 6, 2026 |
| 14 | Pitigoi CosminChief Financial Officer |  FLYWFlywire CorpOpen-market sale · 10b5-1 plan | SELL | $122K 5,916 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO |  COFCAPITAL ONE FINANCIAL CORPOpen-market sale · 10b5-1 plan | SELL | $1.67M 7,798 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $5.01M 24.6K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Debbi NirDirector, President |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $797K 17.9K sh | Nov 6, 2026 traded Nov 5, 2026 |
| 14 | Tamari ShaharDirector, COO | GLBEGlobal-E Online Ltd. Open-market sale · 10b5-1 plan | SELL | $594K 13.4K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $1.07M 5,315 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Tamari ShaharDirector, COO | GLBEGlobal-E Online Ltd. Open-market sale · 10b5-1 plan | SELL | $627K 14.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $3.79M 18.8K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $2.01M 9,942 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Jackson BenjaminPresident |  ICEIntercontinental Exchange, Inc.Open-market sale · 10b5-1 plan | SELL | $71K 400 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $1.05M 4,929 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 14 | Fairbank Richard DDirector, Chairman and CEO | COFCAPITAL ONE FINANCIAL CORP Open-market sale · 10b5-1 plan | SELL | $1.09M 5,454 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $93K 160 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Patel Sanj KDirector, CHAIRMAN & CEO |  KNSAKiniksa Pharmaceuticals International, plcOpen-market sale · 10b5-1 plan | SELL | $135K 1,460 sh | Nov 6, 2026 traded Nov 4, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $139K 240 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Robinson ElliottDirector |  HNGEHinge Health, Inc.Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Shimanovsky Boris F.EVP, Chief Technology Officer |  ZIPZIPRECRUITER, INC.Open-market sale · 10b5-1 plan | SELL | $141K 30.0K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $100K 167 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $180K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $89K 156 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $159K 280 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $70K 120 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $182K 310 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $95K 160 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Robinson ElliottDirector | HNGEHinge Health, Inc. Open-market sale | SELL | — 0 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $166K 280 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $71K 120 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $183K 306 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $142K 237 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Kelly Roland ThomasChief Legal Officer and GC |  VELVelocity Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 3,200 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $193K 330 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $215K 375 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $184K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K